Literature DB >> 25806321

EGFR, EGFR TKI, and EMSI: a never-ending story.

Young-Chul Kim1.   

Abstract

Entities:  

Year:  2014        PMID： 25806321      PMCID： PMC4367677          DOI： 10.3978/j.issn.2218-6751.2014.09.10

Source DB:  PubMed          Journal:  Transl Lung Cancer Res        ISSN： 2218-6751


× No keyword cloud information.
  2 in total

1.  Gefitinib treatment in EGFR mutated caucasian NSCLC: circulating-free tumor DNA as a surrogate for determination of EGFR status.

Authors:  Jean-Yves Douillard; Gyula Ostoros; Manuel Cobo; Tudor Ciuleanu; Rebecca Cole; Gael McWalter; Jill Walker; Simon Dearden; Alan Webster; Tsveta Milenkova; Rose McCormack
Journal:  J Thorac Oncol       Date:  2014-09       Impact factor: 15.609

2.  EGFR mutation detection in ctDNA from NSCLC patient plasma: A cross-platform comparison of leading technologies to support the clinical development of AZD9291.

Authors:  Kenneth S Thress; Roz Brant; T Hedley Carr; Simon Dearden; Suzanne Jenkins; Helen Brown; Tracey Hammett; Mireille Cantarini; J Carl Barrett
Journal:  Lung Cancer       Date:  2015-10-09       Impact factor: 5.705
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.